Navigation Links
Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
Date:9/21/2007

by calling 1-800-896-5855.

In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Cephalon's current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs; development of potential pharmaceutical products, including the results of any clinical programs with respect to TREANDA or the timing or acceptance of any current or future filings for regulatory approval of TREANDA or other Cephalon Oncology compounds; interpretation of clinical results, particularly with respect to the TREANDA clinical trials; manufacturing development and capabilities; market prospects for its products; sales and earnings guidance; and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" or other words and terms of similar meaning. Cephalon's performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more specific risks and uncertainties facing Cephalon such as those set forth in its reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermore, Cephalon does not intend to update publicly any forward-looking statement, except as required by law. The Private Securities Litigation Reform Act of 1995 permits this discussion.


'/>"/>
SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. A Versatile Power Supply for All Electrophoresis Applications
2. Highest Possible Transformation Efficiencies for High-Throughput Applications
3. Unique DNA Polymerase Formulation Excels in a Broad Range of PCR Applications
4. High-Throughput System Generates Ultra-Pure PCR Products Suitable for All Applications
5. An Assessment of the Eppendorf twin.tec plate performance in PCR* applications
6. Principles and applications of electrical cell fusion
7. Eppendorf Electroporation Application Notes Your participation is highly welcome !!!
8. Optimizing Büchi® Rotary Evaporator Applications
9. Principles and applications of electrical cell fusion
10. Eppendorf Electroporation Application Notes Your participation is highly welcome !!!
11. Optimizing Büchi® Rotary Evaporator Applications

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...ewswire-FirstCall/ -- BioSpecifics Technologies Co...developing first-in-class collagenase-based produc...third quarter ended September 30, 2009. ,, "We...ear, the FDA,s Arthritis Advisory Committee unanim... of XIAFLEX(TM) for the treatment of Dupuytren,s d...
(Date:11/5/2009)...wswire/ -- SpineSmith Partners has signed an initi...nique scaffold that mimics the structure of natura...l commercial products by SpineSmith,s Research and...GenOsteo scaffold represents a significant advance... environment for the delivery of adult stem cells ...
(Date:11/4/2009)...binar, which will be presented on November 19 and ...w chemistry processing, will deal with the applica... meso and micro scale flow chemistry equipment. P...een recognized with several prestigious prizes and...ron Prize. , Columbia, MD...
(Date:11/4/2009)... Onyx Pharmaceuticals, In...resent at the Credit Suisse 18th Annual Healthcare.... Mountain Time (8:30 a.m. Pacific Time). Interes...ntation on our website at: http://www.onyx-pharm...mmended that listeners log on 15 minutes early in ...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3
... Feb. 4 Art,s Way Manufacturing, Inc. (Nasdaq: ...,s Way Scientific, Inc. - Buildings For Science - ...sforscience.com/ The new site, reflective of the ..., clean and more user-friendly. , , Art,s Way Sci...a leading supplier of custom-designed modular labo...
... Offers New Understanding of Biological and Physic...ize Trust announces the Microgravity Research Comp...avity to advance biotech, nanotech, combustion, me...t and Space Exploration Technologies (SpaceX), the...tion to and from Low Earth Orbit for the winning e...
.... 4 GeoVax Labs, Inc.,(OTC Bulletin Board: GOVX),...al company developing human vaccines for diseases ... other infectious agents, today,announced that its...tor Conference,2009 will be webcast live by Thomso...orf-Astoria Hotel in New York City on February 9 a...
Other Biology Technology:Art's Way Manufacturing Announces Launch of New Web Site For Art's Way Scientific - Buildings For Science 2Art's Way Manufacturing Announces Launch of New Web Site For Art's Way Scientific - Buildings For Science 3Heinlein Trust and SpaceX Announce Competition to Promote Research Innovation in Zero Gravity 2Heinlein Trust and SpaceX Announce Competition to Promote Research Innovation in Zero Gravity 3GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference 2GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference 3
(Date:11/6/2009)...ETROIT, Nov. 6 Auburn Hills, MI-ba...) will be installing its locker system and patent-... at the U.S. Department of Health and Human Servic...ethesda, MD. The locker system will support the N...rotecting our nation,s medical research agency. T...
(Date:11/5/2009)...State University has been awarded a training grant...ce Foundation under its Integrative Graduation Edu... is the first IGERT grant to be awarded to Kent St... Recovery and Reinvestment Act of 2009, runs throu... focuses on environment aquatic resource sensing (...
(Date:11/4/2009)...ouis, MO, November 4, 2009 Childhood obesity in t... With more than one fourth of advertising on dayti...beverages and continuing questions about the role ...er/December issue of the Journal of Nutrition Edu... aimed at children might be a large contributor to...
Breaking Biology News(10 mins):Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Cradle and birthday of dog identified 9751 1All Eyes on The Medical Home 3A Patient Centered Primary Care Collaborative Convenes National Summit In Washington DC 55867 1All Eyes on The Medical Home 3A Patient Centered Primary Care Collaborative Convenes National Summit In Washington DC 55867 2All Eyes on The Medical Home 3A Patient Centered Primary Care Collaborative Convenes National Summit In Washington DC 55867 3AMR Research Analyst Named One of the Most Inspiring Individuals in Life Sciences by PharmaVOICE 55863 1AMR Research Analyst Named One of the Most Inspiring Individuals in Life Sciences by PharmaVOICE 55863 2AMR Research Analyst Named One of the Most Inspiring Individuals in Life Sciences by PharmaVOICE 55863 3
...study provides insight into a calcium-sensing enzy...beats and other critical functions. The researcher...M kinase II), contributes to arrhythmia in an extr...t inhibiting the enzyme prevents irregular heartbe...ar model, could help with developing treatments fo...
... The University of Queensland could contribute to ...e virus and Dengue fever. , Led by Associate Pro...rom UQ,s School of Molecular and Microbial Science...amily to which these diseases belong. , The team...which, among other functions, controlled the host,...
....Y. Much like cancer cells, plant cells grown for...lture dishes, have highly unstable genomes. Change...help cells cope with challenging culture condition...regulation by transposons -- bits of DNA that can ...to random genetic locations, often disrupting norm...
Other Biology News:Rare disease provides clues about enzyme role in arrhythmias 2Rare disease provides clues about enzyme role in arrhythmias 3UQ research targets West Nile virus and dengue fever 2CSHL researchers map changing epigenetic modifications that enable transposons to run amok 2
EZ-Chip from Upstate
...or the PDS-1000 He biolistic system enables 7-10 t...d system. It fits into the shocking chamber of the...ock wave over 7 microcarriers. By uniformly spread... this larger area, the system maximizes the number...
Acetyl-Histone H3 Immunoprecipitation (ChIP) Assay Kit from Upstate
...itochondrial transmembrane potential is one of the...g induction of apoptosis. The MitoLight Apoptosis...d as MitoLight, as a mitochondrial activity marker...ochondria in living cells in a membrane potential-...
Biology Products: